Journal Title：International Journal Of Clinical Oncology

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

《國(guó)際臨床腫瘤學(xué)雜志》（IJCO）歡迎有關(guān)臨床腫瘤學(xué)各個(gè)方面的原創(chuàng)研究論文，報(bào)告新穎且及時(shí)的研究結(jié)果。鼓勵(lì)提交臨床試驗(yàn)報(bào)告。如果實(shí)驗(yàn)研究與臨床腫瘤學(xué)有明顯相關(guān)性，也將接受。日本臨床腫瘤學(xué)會(huì)的會(huì)員資格不是向該雜志投稿的先決條件。提交論文的前提是：論文內(nèi)容未在其他地方全部或部分發(fā)表過(guò)；論文必須經(jīng)過(guò)至少兩名審稿人和編輯的同行評(píng)審，并且必須對(duì)語(yǔ)言和內(nèi)容進(jìn)行編輯修訂；編輯負(fù)責(zé)論文的接受、拒絕和出版順序。

International Journal Of Clinical Oncology創(chuàng)刊于1996年，由Springer Singapore出版商出版，收稿方向涵蓋醫(yī)學(xué) - 腫瘤學(xué)全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過(guò)審相對(duì)來(lái)講不是特別難，但是該刊專業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約2月 ，影響因子指數(shù)2.4，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。